Douglas Crandell, Eric Furman, Ph.D. Drug development programs face unique challenges in demonstrating the safety and effectiveness of drugs for treating rare diseases. The FDA’s Accelerating Rare ...
Whereas cardiovascular disease-related mortality has declined in most developed countries, its known prevalence is increasing worldwide, although few data on the causes of heart disease in the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results